Injectable testosterone undecanoate with oral or injectable norethisterone preparations for male contraception
Kamischke, A.; Heuermann, T.; Krueger, K.; Von Eckardstein, S.; Nieschlag, E.
Journal of Andrology (Suppl): 193
2001
ISSN/ISBN: 0196-3635 Document Number: 398273
Document emailed within 1 workday
Related Documents
Kamischke, A.; Heuermann, T.; Krüger, K.; von Eckardstein, S.; Schellschmidt, I.; Rübig, A.; Nieschlag, E. 2002: An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations Journal of Clinical Endocrinology and Metabolism 87(2): 530-539Cui, Y.; Zhu, H.; Zhu, Y.; Guo, X.; Huo, R.; Wang, X.; Tong, J.; Qian, L.; Zhou, Z.; Jia, Y.; Lue, Y.-H.; Hikim, A.S.; Wang, C.; Swerdloff, R.S.; Sha, J. 2008: Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptive Journal of Proteome Research 7(9): 3984-3993
Liu, S-Tian.; Gui, Y-Lun.; Lin, C-Hong.; He, C-Hai. 2004: Hormonal contraception in Chinese men: variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants Asian Journal of Andrology 6(1): 41-46
Liu, S-Tian.; Gui, Y-Lun.; Lin, C-Hong.; He, C-Hai. 2004: Hormonal contraception in Chinese men: variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants Asian Journal of Andrology 6(1): 41-46
Misro, M.M.; Chaki, S.P.; Kaushik, M.C.; Nandan, D. 2009: Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats Contraception 79(6): 488-497
Giwa-osagie, O.F.; Newton, J.R. 1982: Injectable norethisterone enanthate contraception: absence of an effect on oral glucose tolerance Contraceptive Delivery Systems 3(1): 61-62
Gu, Y.; Liang, X.; Wu, W.; Liu, M.; Song, S.; Cheng, L.; Bo, L.; Xiong, C.; Wang, X.; Liu, X.; Peng, L.; Yao, K. 2009: Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men Journal of Clinical Endocrinology and Metabolism 94(6): 1910-1915
Gonzalo, I.T.Gaw.; Swerdloff, R.S.; Nelson, A.L.; Clevenger, B.; Garcia, R.; Berman, N.; Wang, C. 2002: Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone Journal of Clinical Endocrinology and Metabolism 87(8): 3562-3572
Gonzalo, I.T.Gaw.; Swerdloff, R.S.; Nelson, A.L.; Clevenger, B.; Garcia, R.; Berman, N.; Wang, C. 2002: Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone Journal of Clinical Endocrinology and Metabolism 87(8): 3562-3572
Kamischke, A.; Plöger, D.; Venherm, S.; von Eckardstein, S.; von Eckardstein, A.; Nieschlag, E. 2000: Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception Clinical Endocrinology 53(1): 43-52
Zathurecky, L.; Bauerova, O.; Somoskeoey, G.; Molnar, L.; Suchy, S. 1963: Stability of Cardenolides of the Strophanthidin type in Injectable Preparations. Iii. Preparations of Stable Injectable Solutions of Helveticoside Ceskoslovenska Farmacie 12: 171-177
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Baweja, R.; Bhattacharya, S.K.; Choudhury, S.D.; Krishna, U.; Manuel, M.; Phillips, F.S.; Datey, S.; Kumar, S.; Mehta, S.; Saxena, N.C. 1985: Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive Contraception 32(4): 383-394
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
P Vathanasiritham; T Siriwong; S.W.rawatgoompa 1986: The pharmacokinetic study of monthly injectable norethisterone enanthate plus estradiol valerate and norethisterone enanthate alone Journal of Steroid Biochemistry 25(supp-S1): 1
P Vathanasiritham; T Siriwong; S.W.rawatgoompa 1986: The pharmacokinetic study of monthly injectable norethisterone enanthate plus estradiol valerate and norethisterone enanthate alone Journal of Steroid Biochemistry 25(supp-S1): 1
McCoy, S.I.; Zheng, W.; Montgomery, E.T.; Blanchard, K.; van der Straten, A.; de Bruyn, G.; Padian, N.S. 2013: Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa Aids 27(6): 1001-1009
Gray, R.H. 1979: Norethisterone oenanthate as an injectable contraceptive British Medical Journal 1(6159): 343